Insulin treatment reverses the increase in atrogin-1 expression in atrophied skeletal muscles of diabetic rats with acute joint inflammation
| dc.contributor.author | Pinheiro-Dardis, Clara Maria [UNESP] | |
| dc.contributor.author | Gutierres, Vânia Ortega [UNESP] | |
| dc.contributor.author | Assis, Renata Pires [UNESP] | |
| dc.contributor.author | Peviani, Sabrina Messa | |
| dc.contributor.author | Delfino, Gabriel Borges | |
| dc.contributor.author | Durigan, João Luiz Quagliotti | |
| dc.contributor.author | Salvini, Tania de Fátima | |
| dc.contributor.author | Baviera, Amanda Martins [UNESP] | |
| dc.contributor.author | Brunetti, Iguatemy Lourenço [UNESP] | |
| dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
| dc.contributor.institution | Universidade Federal de São Carlos (UFSCar) | |
| dc.contributor.institution | University of Brasilia | |
| dc.date.accessioned | 2018-12-11T17:18:03Z | |
| dc.date.available | 2018-12-11T17:18:03Z | |
| dc.date.issued | 2018-02-14 | |
| dc.description.abstract | Background: The aim of this study was to evaluate the changes in biomarkers of skeletal muscle proteolysis (atrogin-1, muscle RING finger-1 protein [MuRF-1]) and inflammation (nuclear factor kappa-B) in skeletal muscles of rats under two catabolic conditions, diabetes mellitus (DM) and acute joint inflammation, and the effects of insulin therapy. Materials and methods: Male Wistar rats were divided into groups without diabetes – normal (N), saline (NS), or ι-carrageenan (NCa) injection into the tibiotarsal joint – and groups with diabetes – diabetes (D), plus insulin (DI), saline (DS), or ι-carrageenan (DCa) injection into the tibiotarsal joint, or ι-carrageenan injection and treatment with insulin (DCaI). Three days after ι-carrageenan injection (17 days after diabetes induction), tibialis anterior (TA) and soleus (SO) skeletal muscles were used for analysis. Results: DM alone caused a significant decrease in the mass of TA and SO muscles, even with low levels of atrogenes (atrogin-1, MuRF-1), which could be interpreted as an adaptive mechanism to spare muscle proteins under this catabolic condition. The loss of muscle mass was exacerbated when ι-carrageenan was administered in the joints of diabetic rats, in association with increased expression of atrogin-1, MuRF-1, and nuclear factor kappa-B. Treatment with insulin prevented the increase in atrogin-1 (TA, SO) and the loss of muscle mass (SO) in diabetic-carrageenan rats; in comparison with TA, SO muscle was more responsive to the anabolic actions of insulin. Conclusion: Acute joint inflammation overcame the adaptive mechanism in diabetic rats to prevent excessive loss of muscle mass, worsening the catabolic state. The treatment of diabetic-carrageenan rats with insulin prevented the loss of skeletal muscle mass mainly via atrogin-1 inhibition. Under the condition of DM and inflammation, muscles with the prevalence of slow-twitch, type 1 fibers were more responsive to insulin treatment, recovering the ability to grow. | en |
| dc.description.affiliation | São Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical Analysis | |
| dc.description.affiliation | Federal University of São Carlos (UFSCar) Department of Physical Therapy | |
| dc.description.affiliation | Physical Therapy Division University of Brasilia | |
| dc.description.affiliationUnesp | São Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical Analysis | |
| dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
| dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
| dc.description.sponsorshipId | FAPESP: 2010/00892–0 | |
| dc.format.extent | 275-286 | |
| dc.identifier | http://dx.doi.org/10.2147/TCRM.S142948 | |
| dc.identifier.citation | Therapeutics and Clinical Risk Management, v. 14, p. 275-286. | |
| dc.identifier.doi | 10.2147/TCRM.S142948 | |
| dc.identifier.issn | 1178-203X | |
| dc.identifier.issn | 1176-6336 | |
| dc.identifier.scopus | 2-s2.0-85042160892 | |
| dc.identifier.uri | http://hdl.handle.net/11449/175901 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Therapeutics and Clinical Risk Management | |
| dc.relation.ispartofsjr | 0,748 | |
| dc.rights.accessRights | Acesso restrito | pt |
| dc.source | Scopus | |
| dc.subject | Atrogenes | |
| dc.subject | Creatine kinase | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Inflammation | |
| dc.subject | Insulin | |
| dc.subject | Muscle proteolysis | |
| dc.subject | NF-κB | |
| dc.title | Insulin treatment reverses the increase in atrogin-1 expression in atrophied skeletal muscles of diabetic rats with acute joint inflammation | en |
| dc.type | Artigo | pt |
| dspace.entity.type | Publication | |
| relation.isDepartmentOfPublication | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| relation.isDepartmentOfPublication.latestForDiscovery | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| unesp.author.lattes | 3736475025187750[8] | |
| unesp.author.orcid | 0000-0003-0987-5295[8] | |
| unesp.department | Análises Clínicas - FCF | pt |
